Arcellx, Inc. — Investor Relations & Filings
Arcellx, Inc. is a clinical-stage biotechnology company that develops immunotherapies for patients with cancer and autoimmune diseases. The company is focused on reimagining cell therapy through its proprietary D-Domain technology. This technology is the foundation for its two main platforms: ddCAR, which produces autologous and allogeneic CAR-T therapies, and ARC-SparX, which involves controllable and adaptable cell therapies. Arcellx's lead investigational product, CART-ddBCMA, is in clinical development for the treatment of relapsed or refractory multiple myeloma. The company aims to create therapies that are safer, more effective, and more broadly accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 POS - Arcellx, Inc. (0001786205) (Filer) | 2026-04-28 | English | |
| 25-NSE - Arcellx, Inc. (0001786205) (Subject) | 2026-04-28 | English | |
| 10-K/A - Arcellx, Inc. (0001786205) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G/A - Arcellx, Inc. (0001786205) (Subject) | 2026-03-26 | English | |
| 4 - Arcellx, Inc. (0001786205) (Issuer) | 2026-03-19 | English | |
| 4 - ARCELLX, INC. (0001786205) (Filer) | 2026-03-04 | English |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
|
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals a…
|
ALEMBICLTD | IN | Manufacturing |
|
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and…
|
APLLTD | IN | Manufacturing |
|
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across mul…
|
ALIVUS | IN | Manufacturing |
Arcellx, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31114/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31114 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31114 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31114 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31114}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Arcellx, Inc. (id: 31114)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.